Our intranasal delivery system will be an exciting alternative to epinephrine auto-injectors, providing patients with a needle-free option that is easy to use, portable, and affordable. With a recent $26.72M Venture Round investment on 10th May 2023, Bryn Pharma is making significant strides in the Health Care and Pharmaceutical industries. The company's innovative approach and commitment to empowering patients at risk for anaphylaxis position it as a compelling investment opportunity in the healthcare sector.
Bryn Pharma
We are creating a better way to empower patients at risk for anaphylaxis
Founded 2016
17 employees
Series Unknown
Total: $125.19M
Health Care, Pharmaceutical
General Information
Get notified when Bryn Pharma moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Bryn Pharma
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
Health Care
About Bryn Pharma
Taxonomy: pharmaceuticals, anaphylaxis, intranasal delivery system, epinephrine, allergy products, patient empowerment, innovation, needle-free technology, portable medical devices
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 10 May 2023 | |
| Venture Round | •••••• | 3 |
|
19 Jul 2021 |
| Venture Round | •••••• | 1 |
|
05 Aug 2020 |
| Series A | •••••• | - | 01 Feb 2020 | |
| Venture Round | •••••• | - | 24 Oct 2019 |
Bryn Pharma Alternatives & Competitors
Bryn Pharma vs
Pioneering advanced immunotherapies to amplify cancer treatment options and improve patient outcomes...
Series C
11-50 employees
Biotechnology, Health and Wellness
Bryn Pharma vs
Healthcare Consultancy Group - HCG
United States
Accelerating the Impact of Science.
624 employees
Advertising, Health Care
Bryn Pharma vs
Eularis
United Kingdom
Accelerating pharma business results using Artificial Intelligence.
5 employees
AI, Health Care
FAQ About Bryn Pharma
We are creating a better way to empower patients at risk for anaphylaxis
Bryn Pharma was founded in 2016.
Bryn Pharma operates in the following industries: Health Care, Pharmaceutical.
Bryn Pharma has approximately 17 employees.
Bryn Pharma has completed 7 funding rounds, raising a total of $125.19M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Bryn Pharma include Checkmate Pharmaceuticals, Healthcare Consultancy Group - HCG, Eularis, Epiodyne, Covis Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bryn Pharma and Checkmate Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Bryn Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.